Last updated: 23 July 2019 at 5:34pm EST

Joseph H Jr Sherrill Net Worth




The estimated Net Worth of Joseph H Jr Sherrill is at least $3.8 Million dollars as of 6 August 2003. Joseph Sherrill owns over 7,700 units of Biocryst Pharmaceuticals stock worth over $3,803,160 and over the last 21 years Joseph sold BCRX stock worth over $0.

Joseph Sherrill BCRX stock SEC Form 4 insiders trading

Joseph has made over 3 trades of the Biocryst Pharmaceuticals stock since 2003, according to the Form 4 filled with the SEC. Most recently Joseph bought 7,700 units of BCRX stock worth $36,575 on 6 August 2003.

The largest trade Joseph's ever made was buying 7,700 units of Biocryst Pharmaceuticals stock on 6 August 2003 worth over $36,575. On average, Joseph trades about 1,914 units every 1 days since 2003. As of 6 August 2003 Joseph still owns at least 492,000 units of Biocryst Pharmaceuticals stock.

You can see the complete history of Joseph Sherrill stock trades at the bottom of the page.



What's Joseph Sherrill's mailing address?

Joseph's mailing address filed with the SEC is 2190 PARKWAY LAKE DR, , BIRMINGHAM, AL, 35244.

Insiders trading at Biocryst Pharmaceuticals

Over the last 24 years, insiders at Biocryst Pharmaceuticals have traded over $76,362,383 worth of Biocryst Pharmaceuticals stock and bought 4,042,003 units worth $20,848,654 . The most active insiders traders include Partners L P/Ilbiotechnolog..., Brothers Life Sciences Capi..., and Carl L Gordon. On average, Biocryst Pharmaceuticals executives and independent directors trade stock every 31 days with the average trade being worth of $542,329. The most recent stock trade was executed by Amy E Mc Kee on 24 June 2024, trading 8,600 units of BCRX stock currently worth $54,352.



What does Biocryst Pharmaceuticals do?

biocryst pharmaceuticals, a biotechnology company, designs, optimizes and develops novel small-molecule drugs that block key enzymes involved in infectious and rare diseases. founded in 1986, biocryst has more than 50 employees and is experiencing continued growth. the company’s headquarters are located in research triangle park, north carolina and its discovery center of excellence is in birmingham, alabama. with expertise in drug discovery, clinical development, regulatory affairs and product commercialization, we continue to advance our clinical programs and to generate new compounds from our own discovery engine. we are proud of our culture of engagement and accountability that rewards people for innovative thinking and achievement of key objectives. the commitment of biocryst remains unchanged. we continue to be passionate about developing and marketing novel therapeutics for patients with rare and serious diseases.



What does Biocryst Pharmaceuticals's logo look like?

Biocryst Pharmaceuticals Inc. logo

Complete history of Joseph Sherrill stock trades at Biocryst Pharmaceuticals

Date
#
Company
Insider
Trans.
Transaction
Shares Price per share Total value Shares after Source
6 Aug 2003 Joseph H Jr Sherrill
Director
Buy 7,700 $4.75 $36,575
6 Aug 2003
492,000
4 Aug 2003 Joseph H Jr Sherrill
Director
Buy 2,100 $4.05 $8,505
4 Aug 2003
484,300
1 Aug 2003 Joseph H Jr Sherrill
Director
Buy 3,600 $3.99 $14,364
1 Aug 2003
482,200


Biocryst Pharmaceuticals executives and stock owners

Biocryst Pharmaceuticals executives and other stock owners filed with the SEC include: